Bispecific and Immune Checkpoint Webinar
The rate at which the bispecific and immune checkpoint modulator landscapes are expanding is both promising and not without challenges; having access to this accurate and comprehensive information is paramount to informed decision-making.
To conclude our landscape review series, and to explore the array of data available across the bispecific and checkpoint landscapes, our research experts explored the drug and trial report data across both modalities and provided further exclusive insights. Key aspects explored included:
A mid-year review of the drug landscape, discussing the 2000+ and 1700+ drugs respectively documented on Beacon
An exploration of the current trial landscape, including all newly identified studies within H1 2023
Insights into the effect of emerging trends and what we can expect in the future
Our Experts
Flavio Lima Bianchi
House Speaker
Lead Research Analyst
Beacon
Zer En Peng
House Speaker
Lead Research Analyst
Beacon
You May Also Be Interested In…
Learn More About Bispecific
- The Most Comprehensive Way to Search the Bispecific Drug Development Landscape: Unique search ontologies based on Bispecific drug and trial characteristics
- Market Leading Approach to Bispecific Preclinical & Clinical Data Curation: Manual curation of key Bispecific research and development data points Bispecific research scientists
- Seamlessly Integrate Commercial & Scientific Data all in One Place: Search Bispecific company and deal data based on their pipeline and technologies.
- Unrivalled Granularity in Reports & Analysis: Our search ontology and technology indexing enable comprehensive analysis not seen elsewhere.
What is Beacon?
Beacon is the essential intelligence platform for R&D decision-makers working in pharma and biotech, offering unique technology and drug datasets for complex therapeutics and disease areas.
Our market-defining proprietary ontologies, manual data curation, and accurate and comprehensive life science data, provide our customers with unparalleled visibility of the drug, trial and commercial landscape.
This is why 24 of the top 25 pharmaceutical companies trust Beacon to power their critical pipeline, competitive, and commercial decisions.
We’d welcome the opportunity to show you how Beacon can transform your data strategy. Book your personalized demonstration today!
